| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 0.1 | 0.1 | 0.1 |
| Other income | 0.5 | 0.5 | 0.6 |
| Total income | 0.6 | 0.6 | 0.7 |
| Profit before exceptional items & tax | 0.1 | 0.1 | 0.3 |
| Profit before tax | 0.1 | 0.1 | 0.3 |
| Net profit | 0.0 | 0.1 | -0.1 |
| Operating margin | 16.7% | 16.7% | 42.9% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Revenue, year on year | +0.00% |
|---|
BSE results filing, NSE: EMMESSA. Figures extracted from the filing.
Emmessar Biotech & Nutrition Ltd: key numbers
- Share price
- ₹23.53
- Market cap
- ₹11.76 Cr
- Revenue (annual)
- ₹0.37 Cr
- Net profit (annual)
- ₹0.44 Cr
- P/E (TTM)
- 29.7×Sector 53.1×
- Promoter holding
- 59.53%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Emmessar Biotech & Nutrition Ltd
All →Emmessar Biotech & Nutrition Other Announcement
Emmessar Biotech & Nutrition informed shareholders without registered email addresses about accessing the Annual Report and 34th AGM Notice via the company's website.
Emmessar Biotech & Nutrition Annual General Meeting
Emmessar Biotech & Nutrition Limited has issued a notice for its 34th Annual General Meeting, scheduled to be held on September 29, 2026, via video conferencing.
Emmessar Biotech & Nutrition Q1 FY27 Results: Net Profit ₹0.1 Cr, Down 50.0% YoY
Emmessar Biotech & Nutrition Ltd reported revenue from operations of ₹0.1 Cr (+0.0% YoY) and net profit of ₹0.1 Cr (-50.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.1 Cr · -50.0% YoY
Emmessar Biotech & Nutrition Board Meeting Date
Emmessar Biotech & Nutrition Limited has scheduled a board meeting for August 07, 2026, to consider and approve the financial results for the quarter ended June 30, 2026.
Emmessar Biotech & Nutrition Financial Results
Emmessar Biotech & Nutrition reported a total income of ₹2.41 Crore for FY26. Net profit stood at ₹0.44 Crore, reflecting stable annual performance for investors.
- Value
- ₹2.41 Cr
Emmessar Biotech & Nutrition Board Meeting Date
Emmessar Biotech & Nutrition Ltd has scheduled a Board Meeting for May 12, 2026. The meeting will primarily focus on considering and approving the audited financial results for the year ended March 31, 2026. The trading window will remain closed until May 14, 2026.